Read our recap of some of the biggest FDA-related stories that impacted cardiology in the last month.

Sustainability might not have been the official theme of RSNA 2022, but it was a prevalent topic among vendors, attendees and presenters.

Although the Affordable Care Act eliminated OOP costs for screening mammograms under most insurance plans, that coverage does not carry over to the additional exams that are needed when abnormal findings are uncovered.

CMS has fined hospitals in the past for failing to meet the standards of safe settings under the Medicare Hospital Conditions of Participation.

Ransomware is a growing problem for healthcare providers. At RSNA 2022, two experts examined how leaders can protect their teams and their facilities. 

JoAnn Pushkin, breast cancer survivor and executive director of DenseBreast-info.org, sounded the alarm on the lack of awareness surrounding breast density and its associated cancer risks during a presentation at this year’s annual RSNA meeting.

Human monkeypox disease was given its name in 1970, before WHO established best practices for naming diseases in 2015.

The U.S. Food and Drug Administration (FDA) has approved 501(k) marketing clearance for the prescription mobile app Parky for monitoring Parkinson’s Disease.